May 3, 2018 / 8:19 PM / 4 months ago

BRIEF-Dermira Inc Q1 Loss Per Share $1.42

May 3 (Reuters) - Dermira Inc:

* DERMIRA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* QTRLY LOSS PER SHARE $1.42

* LEBRIKIZUMAB PHASE 2B STUDY ENROLLING PATIENTS, DATA EXPECTED IN FIRST HALF OF 2019

* IF APPROVED BY U.S. FDA, LAUNCH GLYCOPYRRONIUM TOSYLATE FOR TREATMENT OF AXILLARY HYPERHIDROSIS IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below